Synlogic, Inc. (SYBX) stock
SYBXOTCPharmaceutical PreparationsFiscal year ends December 31
$1.07+0.07 (+7.00%)
Close on Oct 19, 2026Market cap $13.29MP/E –Yield –
Synlogic r&d expenses
Research and development expenses are spending on new products and technology.
Synlogic's R&D Expenses for the twelve months ending Jun 30, 2024 was $29.63M, down 43.5% year over year. For fiscal 2025 it was $43.00K, down 99.5% from the year before. Over ten years it grew -45.6% a year on average. The highest annual figure on record is $52.04M in fiscal 2022.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $43.00K | -99.5% |
| FY2024 | Dec 31, 2024 | $9.15M | -79.2% |
| FY2023 | Dec 31, 2023 | $43.97M | -15.5% |
| FY2022 | Dec 31, 2022 | $52.04M | +10.4% |
| FY2021 | Dec 31, 2021 | $47.13M | -0.7% |
| FY2020 | Dec 31, 2020 | $47.47M | +13.3% |
| FY2019 | Dec 31, 2019 | $41.91M | +10.2% |
| FY2018 | Dec 31, 2018 | $38.03M | +25.4% |
| FY2017 | Dec 31, 2017 | $30.34M | +102.1% |
| FY2016 | Dec 31, 2016 | $15.01M | -20.8% |
| FY2015 | Dec 31, 2015 | $18.95M | +79.7% |
| FY2014 | Dec 31, 2014 | $10.55M | +140.2% |
| FY2013 | Dec 31, 2013 | $4.39M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2026 | Mar 31, 2026 | $49.00K | -99.5% |
| Q1 FY2025 | Mar 31, 2025 | $22.00K | -99.8% |
| Q2 FY2024 | Jun 30, 2024 | $2.20M | -81.3% |
| Q1 FY2024 | Mar 31, 2024 | $7.68M | -38.3% |
| Q4 FY2023 | Dec 31, 2023 | $10.14M | -25.7% |
| Q3 FY2023 | Sep 30, 2023 | $9.62M | -34.2% |
| Q2 FY2023 | Jun 30, 2023 | $11.77M | -2.4% |
| Q1 FY2023 | Mar 31, 2023 | $12.45M | +6.1% |
| Q4 FY2022 | Dec 31, 2022 | $13.64M | +14.9% |
| Q3 FY2022 | Sep 30, 2022 | $14.61M | +9.4% |
| Q2 FY2022 | Jun 30, 2022 | $12.06M | +12.5% |
| Q1 FY2022 | Mar 31, 2022 | $11.74M | +5.0% |
| Q4 FY2021 | Dec 31, 2021 | $11.87M | +4.1% |
| Q3 FY2021 | Sep 30, 2021 | $13.36M | +27.4% |
| Q2 FY2021 | Jun 30, 2021 | $10.72M | -17.0% |
| Q1 FY2021 | Mar 31, 2021 | $11.18M | -11.8% |
| Q4 FY2020 | Dec 31, 2020 | $11.41M | +1.4% |
| Q3 FY2020 | Sep 30, 2020 | $10.48M | -0.8% |
| Q2 FY2020 | Jun 30, 2020 | $12.91M | +33.0% |
| Q1 FY2020 | Mar 31, 2020 | $12.68M | +22.1% |
| Q4 FY2019 | Dec 31, 2019 | $11.25M | +26.9% |
| Q3 FY2019 | Sep 30, 2019 | $10.56M | +6.3% |
| Q2 FY2019 | Jun 30, 2019 | $9.70M | -10.8% |
| Q1 FY2019 | Mar 31, 2019 | $10.38M | +24.2% |
| Q4 FY2018 | Dec 31, 2018 | $8.87M | +14.6% |
| Q3 FY2018 | Sep 30, 2018 | $9.93M | +10.9% |
| Q2 FY2018 | Jun 30, 2018 | $10.87M | +27.4% |
| Q1 FY2018 | Mar 31, 2018 | $8.36M | +63.4% |
| Q4 FY2017 | Dec 31, 2017 | $7.74M | +230.5% |
| Q3 FY2017 | Sep 30, 2017 | $8.96M | – |
| Q2 FY2017 | Jun 30, 2017 | $8.53M | – |
| Q1 FY2017 | Mar 31, 2017 | $5.12M | – |
| Q4 FY2016 | Dec 31, 2016 | $2.34M | – |
See a number that looks wrong?